Devdat, Oluwamayowa Bababunmi, Ransirini Tharaka Wijeratne, Madinah Suleiman Usman, Huda Ijaz*, Chidinma Vivian Ikekpeazu, Vivian Samuel Hana Abdelmalak, Mohammed Numaan Ahmed, Taiwo Ogundipe, Nosike C. Obionwu, Abeeb Babatunde Oyedele, Edmund Umebani, Aqsa Latif, Adewale Mark Adedoyin9 and Hammad Zafar


In Western countries, the commonest cause of chronic liver disease (CLD) is non-alcoholic fatty liver disease (NAFLD). Ongoing research related to it has enhanced our understanding of the disease progression as well as the effect of this entity on overall morbidity and mortality. NAFLD in its active form is known as nonalcoholic steatohepatitis (NASH), for which, according to the European Medicine Agency, there is no recommended treatment currently. Developing new treatments is challenging as the condition progresses slowly. New data must be used to improve our understanding of the elements that influence the development of NAFLD. This may allow for a more accurate and non-invasive assessment of prognosis. For targeted individual treatment, assessments focussing particularly on populations that are at risk of developing NAFLD are available. The goal of this review paper is to highlight recent discoveries in the field of NAFLD, including pathogenesis, epidemiology, and treatment options. The diagnosis, clinical characteristics, and existing treatment options, including novel targets and medicines, are all discussed.

Keywords: Hepatology, Nonalcoholic fatty liver disease, Review.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    AUGUST 2022 Issue has been successfully launched on 1 August 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction